Sudeep Pharma Financials
NSE: SUDEEPPHRM | BSE: 544619
₹1,329.30
As on 04-Sep-2026 15:59IST
Market cap
₹15,009 Cr
Revenue (TTM)
₹676 Cr
P/E Ratio
82.2
P/B Ratio
16.2
Div. Yield
0.1 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
675.61
|
642.26
|
502.00
|
459.28
|
428.74
|
343.01
|
|||||
|
Total Income
|
704.48
|
670.84
|
511.33
|
465.38
|
438.26
|
350.40
|
|||||
|
Total Expenditure
|
442.67
|
419.46
|
310.99
|
276.81
|
338.58
|
275.55
|
|||||
|
EBITDA
|
232.94
|
222.80
|
191.01
|
182.47
|
90.16
|
67.46
|
|||||
|
Depreciation
|
15.56
|
14.81
|
10.59
|
9.01
|
7.92
|
4.53
|
|||||
|
EBIT
|
217.38
|
207.99
|
180.42
|
173.46
|
82.24
|
62.93
|
|||||
|
Interest
|
7.96
|
8.50
|
6.90
|
4.74
|
5.78
|
1.72
|
|||||
|
Other Income
|
28.87
|
28.59
|
9.33
|
6.10
|
9.52
|
7.39
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
238.30
|
228.07
|
182.85
|
174.82
|
85.98
|
68.60
|
|||||
|
Provision for Tax
|
54.69
|
53.79
|
44.12
|
41.63
|
23.66
|
18.44
|
|||||
|
Profit after Tax
|
183.60
|
174.28
|
138.73
|
133.19
|
62.32
|
50.17
|
|||||
|
Minority Interest
|
-0.97
|
-1.39
|
--
|
--
|
--
|
--
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
182.64
|
172.89
|
138.73
|
133.19
|
62.32
|
50.17
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
883.34
|
883.34
|
493.09
|
356.03
|
223.29
|
163.34
|
|||||
|
Minority Interest
|
-0.97
|
14.75
|
--
|
--
|
--
|
--
|
|||||
|
Non-Current Liabilities
|
74.82
|
74.33
|
49.00
|
20.38
|
25.46
|
33.48
|
|||||
|
Current Liabilities
|
201.96
|
201.96
|
174.76
|
137.22
|
170.83
|
146.98
|
|||||
|
Total Liabilities
|
1,174.88
|
1,174.38
|
716.85
|
513.64
|
419.57
|
343.80
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
477.92
|
550.42
|
292.73
|
238.27
|
189.55
|
147.20
|
|||||
|
Current Assets
|
623.97
|
623.97
|
424.12
|
275.36
|
230.02
|
196.61
|
|||||
|
Total Assets
|
1,174.88
|
1,174.38
|
716.85
|
513.64
|
419.57
|
343.80
|
|||||
|
Total Debt*
|
--
|
148.29
|
135.25
|
74.90
|
82.20
|
83.69
|
|||||
|
Net Current Assets
|
422.01
|
422.00
|
249.36
|
138.14
|
59.19
|
49.63
|
|||||
|
Contingent Liabilities
|
--
|
--
|
0.10
|
0.10
|
0.10
|
0.26
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
69.55
|
48.73
|
65.69
|
48.40
|
-2.98
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-330.93
|
-78.76
|
-49.28
|
-50.02
|
-38.42
|
|||||
|
Cash from Financing Activities
|
--
|
247.29
|
52.70
|
-12.74
|
-9.78
|
50.92
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-14.09
|
22.67
|
3.67
|
-11.40
|
9.52
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
16.82
|
15.31
|
14.27
|
13.72
|
6.42
|
5.17
|
|||||
|
Cash EPS (₹)
|
16.17
|
16.74
|
15.36
|
14.65
|
7.23
|
5.63
|
|||||
|
Adjusted Book Value (₹)
|
81.80
|
78.21
|
50.48
|
36.67
|
23.00
|
16.82
|
|||||
|
Dividend per Share (₹)
|
0.11
|
1.50
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
6.16
|
5.01
|
466.18
|
343.47
|
-21.17
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-3.64
|
-2.46
|
84.37
|
-70.88
|
-553.22
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
28.50
|
35.83
|
48.76
|
33.22
|
35.85
|
|||||
|
ROE (%)
|
22.72
|
25.37
|
32.76
|
45.98
|
32.24
|
36.15
|
|||||
|
ROA (%)
|
31.25
|
18.43
|
22.55
|
28.54
|
16.33
|
18.03
|
|||||
|
EBIT Margin (%)
|
32.18
|
32.38
|
35.94
|
37.77
|
19.18
|
18.35
|
|||||
|
Net Margin (%)
|
26.06
|
25.98
|
27.13
|
28.62
|
14.22
|
14.32
|
|||||
|
Cash Profit Margin (%)
|
--
|
28.90
|
28.51
|
30.96
|
16.38
|
15.95
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
23.56
|
27.94
|
9.30
|
7.12
|
24.99
|
59.46
|
|||||
|
EBIT Growth (%)
|
12.00
|
15.28
|
4.01
|
110.90
|
30.69
|
55.18
|
|||||
|
Net Profit Growth (%)
|
19.80
|
25.63
|
4.16
|
113.71
|
24.23
|
50.46
|
|||||
|
EPS Growth (%)
|
50.65
|
7.28
|
4.01
|
113.71
|
24.24
|
50.46
|
|||||
|
Book Value Growth (%)
|
--
|
79.97
|
37.86
|
59.45
|
36.70
|
43.02
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
82.18
|
38.70
|
--
|
--
|
--
|
--
|
|||||
|
Price / Book Value
|
16.25
|
7.57
|
--
|
--
|
--
|
--
|
|||||
|
Dividend Yield (%)
|
0.11
|
0.25
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
57.46
|
26.75
|
0.48
|
0.33
|
0.74
|
0.85
|
|||||
|
Close Price (₹)
|
848.50
|
592.55
|
--
|
--
|
--
|
--
|
|||||
|
High Price (₹)
|
883.20
|
795.80
|
--
|
--
|
--
|
--
|
|||||
|
Low Price (₹)
|
524.05
|
524.05
|
--
|
--
|
--
|
--
|
|||||
|
Market Cap (₹ Cr)
|
15,009.18
|
6,690.53
|
--
|
--
|
--
|
--
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.04
|
0.17
|
0.27
|
0.21
|
0.37
|
0.51
|
|||||
|
Short term debt to equity ratio
|
--
|
0.12
|
0.17
|
0.15
|
0.23
|
0.34
|
|||||
|
Current Ratio
|
3.09
|
3.09
|
2.43
|
2.01
|
1.35
|
1.34
|
|||||
|
Quick Ratio
|
2.02
|
2.02
|
1.69
|
1.53
|
0.93
|
1.09
|
|||||
|
Interest Coverage
|
30.94
|
27.82
|
27.49
|
37.92
|
15.87
|
40.89
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
33.68
|
35.43
|
36.92
|
31.48
|
21.86
|
31.17
|
|||||
|
Asset Turnover
|
1.15
|
0.69
|
0.85
|
0.98
|
1.12
|
1.23
|
|||||
|
Receivable days
|
--
|
115.16
|
114.95
|
94.68
|
85.40
|
86.25
|
|||||
|
Inventory Days
|
--
|
96.15
|
68.03
|
54.67
|
45.77
|
28.73
|
|||||
|
Payable days
|
--
|
106.08
|
133.44
|
100.79
|
68.31
|
63.28
|
|||||
|
Cash Conversion Cycle
|
--
|
105.23
|
49.53
|
48.56
|
62.87
|
51.70
|